Mouse Myeloproliferative Disease
specificA. Erythrocytosis, leukocytosis of myeloid cells, or thrombocytosis/circulating megakaryocytes AND B. Increased non-lymphoid hematopoietic cells in spleen and/or bone marrow; Comment: may be designated as having features of a named human MD/MPD or MPD
Top Centers for Mouse Myeloproliferative Disease
Ranked by research excellence score (trials · grants · publications). Methodology →
No centers currently specializing in this cancer type.
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →